CVS Health and UnitedHealth Group seek recusal of FTC Chair Lina Khan and others from PBM insulin price suit over perceived bias.

CVS Health and UnitedHealth Group have requested the recusal of FTC Chair Lina Khan and two other commissioners from a lawsuit alleging that major pharmacy benefit managers (PBMs) inflated insulin prices. The companies argue the commissioners have shown bias against PBMs through public statements. The FTC's lawsuit, filed in September, accuses CVS Caremark, UnitedHealth's Optum Rx, and Cigna's Express Scripts of unfair practices that harm patients.

October 09, 2024
18 Articles